Holding(S) In Company

2025-05-08 10:01:21

(MENAFN- GlobeNewsWire - Nasdaq) TR-1: Standard form for notification of major holdings

1. Issuer Details
ISIN
GB00BNR4T868
Issuer Name
RENEWI PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of financial instruments
3. Details of person subject to the notification obligation
Name
Bank of America Corporation
City of registered office (if applicable)

Country of registered office (if applicable)
US
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached
06-May-2025
6. Date on which Issuer notified
07-May-2025
7. Total positions of person(s) subject to the notification obligation

.	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	0.409625	10.064216	10.473841	8437670
Position of previous notification (if applicable)	0.000000	5.420328	5.420328

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BNR4T868		329992		0.409625
Sub Total 8.A	329992	0.409625%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Physical Swaps	14/05/2025	N/A	845980	1.050131
Physical Swaps	19/02/2026	N/A	823142	1.021782
Right to Recall	N/A	N/A	19748	0.024514
Sub Total 8.B1		1688870	2.096427%

8B2. Financial Instruments with similar economic effect according to (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Swaps	17/09/2025	N/A	Cash	654646	0.812625
Swaps	06/01/2026	N/A	Cash	1742726	2.163279
Swaps	23/02/2026	N/A	Cash	1750915	2.173444
Swaps	18/03/2026	N/A	Cash	4514	0.005603
Swaps	28/04/2026	N/A	Cash	266928	0.331343
Swaps	31/07/2026	N/A	Cash	210757	0.261617
Swaps	02/04/2026	N/A	Cash	1223478	1.518726
Swaps	22/04/2026	N/A	Cash	564844	0.701152
Sub Total 8.B2		6418808	7.967789%

9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Bank of America Corporation	Bank of America, National Association		5.401253	5.401253%
Bank of America Corporation	Merrill Lynch International		4.662961	5.072587%

10. In case of proxy voting
Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion
07-May-2025
13. Place Of Completion
United Kingdom

MENAFN08052025004107003653ID1109524523

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.